Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patientsJanuary 03, 2008Scientists at Thomas Jefferson University Hospital and Jefferson's Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether high doses of vitamin C can slow the progression of the deadly disease. "This is a very unique study for a set of patients who have really run out of options," said Daniel Monti, M.D., director of the Myrna Brind Center of Integrative Medicine, and primary investigator of the study. "Vitamin C administered intravenously has shown great promise in the laboratory and there has been some anecdotal data in cancer patients, but no one has really ever run a detailed study on humans. Vitamin C doesn't cost much and is very low in toxicity, making it a particularly desirable agent for further study." Recent research conducted by the NIH collaborators of this study has shown that when given in sufficient amounts intravenously, vitamin C converts to hydrogen peroxide. When applied to certain non-Hodgkin lymphoma cells in the laboratory, the converted hydrogen peroxide kills them while leaving the surrounding healthy cells intact. "Previous human studies have been flawed because the vitamin C was given orally versus intravenously," said Monti. "The problem with that is the oral route tightly limits the amount of vitamin C that can get into the bloodstream. When vitamin C is given intravenously you can get up to 70 times more of the vitamin into the blood versus the same dose given orally. It is these high blood levels that are required to get the mechanism of action, vitamin C converting to hydrogen peroxide around the cancer cells, to occur. Although other cancers could be a contender for this intervention, the preliminary data on non-Hodgkin lymphoma cells is why we decided to start with this disease." The study will begin with 20 non-Hodgkin lymphoma patients who have failed standard therapy. Each study participant will be given varied intravenous doses of vitamin C three times a week. The patients will be evaluated and monitored for progression of their disease. The study's goals are to show diminished progression of the disease in participating patients. "As leaders in the field of integrative medicine, Jefferson is always seeking new and innovative therapies for our patients," concluded Monti. "We want to look in every corner for solutions. This study is a unique collaboration of several clinical and research specialists. If this study yields positive data we will do further studies to expand the availability of this intriguing therapy." Thomas Jefferson University |
|||||||||||||||||||||
| Related Vitamin C Current Events and Vitamin C News Articles Fruit juices contain more vitamin C than their labels indicate A team of pharmacists from the University of Santiago de Compostela (USC) has established that the levels of vitamin C in many fruit juices and soft drinks are far higher than those indicated on their labels by the manufacturers. First global scientific conference supporting UN efforts to curb desertification opens in Argentina As climate change negotiators continue to skirt the role of agricultural land use in reducing greenhouse gas emissions, top scientists working on land management in the world's vast dry areas will gather this week in Buenos Aires, Argentina, determined to make the case that thwarting desertification in drylands is viable and also critical to the success of a new climate deal. Green tea component may help preserve stored platelets, tissues In two separate studies, a major component in green tea, epigallocatechin-3-O-gallate (EGCG), has been found to help prolong the preservation of both stored blood platelets and cryopreserved skin tissues. Model backs green tea and lemon claim, lessens need to test animals An animal study at Purdue University has shown that adding ascorbic acid and sugar to green tea can help the body absorb helpful compounds and also demonstrates the effectiveness of a model that could reduce the number of animals needed for these types of studies. UAB/Southern Research Scientists Discover How Flu Damages Lung Tissue A protein in influenza virus that helps it multiply also damages lung epithelial cells, causing fluid buildup in the lungs, according to new research from the University of Alabama at Birmingham (UAB) and Southern Research Institute. Melon research sweetened with DNA sequence People smell them, thump them and eyeball their shape. But ultimately, it's sweetness and a sense of healthy eating that lands a melon in a shopper's cart. Many breast cancer patients take high doses of antioxidants despite possible consequences A new study finds that many women with breast cancer take antioxidant supplements while undergoing cancer treatment, even though the consequences of doing so are unknown. Many breast cancer patients take high doses of antioxidants despite possible consequences A new study finds that many women with breast cancer take antioxidant supplements while undergoing cancer treatment, even though the consequences of doing so are unknown. New fuel cell catalyst uses 2 metals Material scientists at Washington University in St. Louis have developed a technique for a bimetallic fuel cell catalyst that is efficient, robust and two to five times more effective than commercial catalysts. Research suggests vegetable juice may help people with metabolic syndrome lose weight Drinking at least one glass of low sodium vegetable juice daily may help overweight people with metabolic syndrome achieve better weight loss results. More Vitamin C Current Events and Vitamin C News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||